Market cap
₹16.1 cr
Loading the extract…
Loading the extract…
Healthcare · Pharmaceuticals
MONOPHARMA · NSE MONOPHARMA
Market cap
₹16.1 cr
Price
9.1
52w high
27.5
52w low
9.05
PE
45.9
Industry PE
—
Book value
17.9
Dividend yield
0%
ROCE
3.46
ROE
1.12
Debt / equity
—
EPS
—
No description in this extract.
| Line | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Depreciation | 0 | 0 | 0 | 0 |
| Dividend Payout % | 0 | 0 | 0 | 0 |
| EPS in Rs | 0.2 | 1.75 | 1.38 | 0.76 |
| Expenses | 162 | 161 | 116 | 31 |
| Interest | 3 | 4 | 3 | 1 |
| Net Profit | 0 | 3 | 2 | 1 |
| OPM % | 2.4 | 4.5 | 5 |
| Line | 2026-03-31 | 2025-09-30 | 2025-03-31 | 2024-09-30 | 2024-03-31 | 2023-09-30 | 2023-03-31 |
|---|---|---|---|---|---|---|---|
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS in Rs | 0.19 | 0.01 | 0.46 | 1.3 | 0.33 | 1.06 | 0.52 |
| Expenses | 97 | 65 | 78 | 82 | 53 | 63 | 33 |
| Interest | 2 | 2 | 2 | 2 | 2 |
| Line | 2025-09-30 | 2025-03-31 | 2024-09-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|---|---|
| Promoters | 56.72 | 56.72 | 56.72 | 56.72 | 56.72 | 56.72 |
| Public | 43.28 | 43.28 | 43.28 | 43.28 | 43.27 | 43.28 |
| 7 |
| Operating Profit | 4 | 8 | 6 | 2 |
| Other Income | 0 | 1 | 0 | 0 |
| Profit before tax | 1 | 4 | 3 | 1 |
| Sales | 166 | 168 | 122 | 33 |
| Tax % | 40 | 30 | 24 | 29 |
| 2 |
| 1 |
| Net Profit | 0 | 0 | 1 | 2 | 1 | 2 | 1 |
| OPM % | 2.2 | 2.7 | 3.6 | 5 | 4.4 | 6 | 6 |
| Operating Profit | 2 | 2 | 3 | 5 | 2 | 4 | 2 |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 1 | 3 | 1 | 2 | 1 |
| Raw PDF | — | — | — | — | — | — | — |
| Sales | 99 | 66 | 81 | 87 | 56 | 67 | 35 |
| Tax % | 29 | 83 | 37 | 27 | 33 | 20 | 39 |